ATE255555T1 - Verfahren zur herstellung von enantiomeren reinem oder optisch angereicherter sertraline-tetralon durch kontinuierliche chromatographie - Google Patents

Verfahren zur herstellung von enantiomeren reinem oder optisch angereicherter sertraline-tetralon durch kontinuierliche chromatographie

Info

Publication number
ATE255555T1
ATE255555T1 AT99920040T AT99920040T ATE255555T1 AT E255555 T1 ATE255555 T1 AT E255555T1 AT 99920040 T AT99920040 T AT 99920040T AT 99920040 T AT99920040 T AT 99920040T AT E255555 T1 ATE255555 T1 AT E255555T1
Authority
AT
Austria
Prior art keywords
tetralone
optically enriched
continuous chromatography
enantiomeric pure
sertraline
Prior art date
Application number
AT99920040T
Other languages
English (en)
Inventor
Oliver Dapremont
Fiona Geiser
Tong Zhang
Subramanian S Guhan
Robert M Guinn
George J Quallich
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE255555T1 publication Critical patent/ATE255555T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99920040T 1998-05-01 1999-04-27 Verfahren zur herstellung von enantiomeren reinem oder optisch angereicherter sertraline-tetralon durch kontinuierliche chromatographie ATE255555T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8385198P 1998-05-01 1998-05-01
PCT/US1999/009037 WO1999057089A1 (en) 1998-05-01 1999-04-27 Process for the production of enantiomerically pure or optically enriched sertraline-tetralone using continuous chromatography

Publications (1)

Publication Number Publication Date
ATE255555T1 true ATE255555T1 (de) 2003-12-15

Family

ID=22181106

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99920040T ATE255555T1 (de) 1998-05-01 1999-04-27 Verfahren zur herstellung von enantiomeren reinem oder optisch angereicherter sertraline-tetralon durch kontinuierliche chromatographie

Country Status (9)

Country Link
US (1) US6444854B1 (de)
EP (1) EP1073618B1 (de)
AT (1) ATE255555T1 (de)
CA (1) CA2342201C (de)
DE (1) DE69913332T2 (de)
DK (1) DK1073618T3 (de)
ES (1) ES2211080T3 (de)
PT (1) PT1073618E (de)
WO (1) WO1999057089A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455736B1 (en) 1994-12-16 2002-09-24 Uop Llc Process for preparation of pharmaceutically desired sertraline and sertraline analogs
US6458955B1 (en) 1994-12-16 2002-10-01 Uop Llc Process for preparation of pharmaceutically desired enantiomers
US6410794B1 (en) 1994-12-16 2002-06-25 Uop Llc Process for preparation of pharmaceutically desired chiral tetralone from tetralones
FR2810978B1 (fr) * 2000-06-29 2004-05-28 Chiralsep Sarl Procede de dedoublement de l'intermediaire tetralone de la sertraline
US6740757B2 (en) 2001-08-29 2004-05-25 Pfizer Inc Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer
US6683220B2 (en) * 2001-10-31 2004-01-27 Pfizer, Inc. Process for the preparation of optically pure or enriched racemic tetralone
US20060128955A1 (en) * 2003-05-09 2006-06-15 Vela Pharmaceuticals, Inc. Method of isolating (R)-tofisopam
PL1658277T3 (pl) * 2003-08-18 2012-10-31 H Lundbeck As Sól bursztynianowa i malonianowa trans-4-((1R,3S)-6-chloro-3-fenyloindan-1-ylo)-1,2,2-tri-metylopiperazyny i zastosowanie jako lek
GB0325055D0 (en) * 2003-10-27 2003-12-03 Smithkline Beecham Corp New process
US20060086667A1 (en) * 2004-09-13 2006-04-27 Cephalon, Inc., U.S. Corporation Methods for the separation of enantiomeric sulfinylacetamides
TWI453198B (zh) 2005-02-16 2014-09-21 Lundbeck & Co As H 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s）-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法
TWI376373B (en) * 2005-02-16 2012-11-11 Lundbeck & Co As H Crystalline base of a pharmaceutical compound
JP2008530039A (ja) * 2005-02-16 2008-08-07 ハー・ルンドベック・アクチエゼルスカベット トランス−１−（（１ｒ，３ｓ）−６−クロロ−３−フェニルインダン−１−イル）−３，３−ジメチルピペラジンの酒石酸塩およびリンゴ酸塩
FR2898283B1 (fr) 2006-03-08 2011-07-15 Novasep Procede et dispositif de separation de fractions d'un melange.
WO2008088830A2 (en) * 2007-01-16 2008-07-24 Evolved Nanomaterial Sciences, Inc. Chiral separating agents with active support
US7776740B2 (en) * 2008-01-22 2010-08-17 Tokyo Electron Limited Method for integrating selective low-temperature ruthenium deposition into copper metallization of a semiconductor device
WO2009135495A1 (en) * 2008-05-07 2009-11-12 H. Lundbeck A/S Method for treating cognitive deficits
BRPI0919165A2 (pt) * 2008-10-03 2015-12-08 Lundbeck & Co As H composição farmacêutica,e, uso de um composto
CN104122342A (zh) * 2014-07-04 2014-10-29 惠州市莱佛士制药技术有限公司 一种盐酸舍曲林中间体(±)-Tetralone及其手性色谱拆分方法
US9127136B1 (en) * 2014-07-18 2015-09-08 Sabic Global Technologies B.V. Purification of monomer from recycle polyesters
CN104826619A (zh) * 2015-05-08 2015-08-12 广州研创生物技术发展有限公司 键合3,5-二甲基苯氨基甲酰化β-环糊精手性固定相在手性分析和/或分离盐酸舍曲林中间体(±)-Tetralone的应用
CN106268657A (zh) * 2015-05-14 2017-01-04 株式会社大赛璐 光学异构体用分离剂
EP3566769B1 (de) 2018-05-07 2023-07-26 Yf1 Simulationsmethode und -vorrichtung einer industrieanlage für die nutzung eines chemischen oder biochemischen verfahrens
EP3786733B1 (de) 2019-08-29 2023-04-12 Yf1 System und verfahren für die simulation eines chemischen oder biochemischen verfahrens
JP2024033070A (ja) * 2022-08-30 2024-03-13 岩崎電気株式会社 異性体調製装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3010816B2 (ja) * 1991-08-22 2000-02-21 ダイセル化学工業株式会社 光学分割における光学異性体と溶媒との回収方法、溶媒の循環使用方法、および光学異性体の再利用方法
EP0577079B1 (de) * 1992-06-30 1999-12-01 Daicel Chemical Industries, Ltd. Trennsystem mit simuliertem Fliessbett
US5466880A (en) * 1992-09-15 1995-11-14 Pfizer Inc. Process for preparing ketone enantiomer
US5288916A (en) * 1993-03-25 1994-02-22 Bend Research, Inc. Enantiomeric resolution of 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
US5630943A (en) * 1995-11-30 1997-05-20 Merck Patent Gesellschaft Mit Beschrankter Haftung Discontinuous countercurrent chromatographic process and apparatus

Also Published As

Publication number Publication date
US6444854B1 (en) 2002-09-03
WO1999057089A1 (en) 1999-11-11
PT1073618E (pt) 2004-03-31
CA2342201A1 (en) 1999-11-11
EP1073618B1 (de) 2003-12-03
DE69913332T2 (de) 2004-05-27
DK1073618T3 (da) 2004-03-15
EP1073618A1 (de) 2001-02-07
CA2342201C (en) 2005-08-09
ES2211080T3 (es) 2004-07-01
DE69913332D1 (de) 2004-01-15

Similar Documents

Publication Publication Date Title
DE69913332D1 (de) Verfahren zur herstellung von enantiomeren reinem oder optisch angereicherter sertraline-tetralon durch kontinuierliche chromatographie
ES2141632A1 (es) Procedimiento para la obtencion de un enantiomero opticamente puro de formoterol.
Schurig Practice and theory of enantioselective complexation gas chromatography
DE69533793D1 (de) Lösungsmittel-extraktionsverfahren
ATE261992T1 (de) Verfahren zur herstellung eines porösen vernetzten polysaccharidgels und seine verwendung als filtermedien und in der chromatographie
WO1996002535A8 (en) Process for synthesis of substituted sulphoxides
IS7064A (is) Aðferð til framleiðslu á essítalóprami
DE69806642D1 (de) Verfahren zur herstellung von xylose
DE69010999D1 (de) Verfahren zur Herstellung von Xylose.
DE59912722D1 (de) Kontinuierliches verfahren zur trennung von stoffen nach molekülgrösse
CA2119674A1 (en) Enantiomeric Resolution of 4-(3,4-Dichlorophenyl)-3,4-Dihydro-1(2H)-Naphthalenone
DE69007800D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin.
ATE364598T1 (de) Verfahren zur herstellung von tetrahydrofuran
ATE423146T1 (de) Verfahren zur herstellung einer katalysatorkomponente basierend auf einem diether
ATE159706T1 (de) Verfahren zur herstellung von chiralen tetralonen
DE60220312D1 (de) Verfahren zur herstellung und fraktionierung von gelbildenden und nicht gelbildenden carrageenanen aus zweikomponentigem tang
DE50308887D1 (de) Verfahren zur herstellung von cellulosecarbamat mittels reaktiver extrusion
NO20001343D0 (no) Fremgangsmåter og sammensetninger for behandling av pulmonære forstyrrelser ved anvendelse av optisk ren (S)-salmeterol
MX9200910A (es) Procedimiento microbiologico para la preparacion de s-(+)-2,2- dimetilciclopropancarboxamida y acido r-(-)-2,2-dimetilciclopropancarboxilico.
DE69533100D1 (de) Füllstoff für hochleistungsflüssigkeitschromatographie und methode zur dessen herstellung
DE69813511D1 (de) Verbessertes verfahren zur herstellung von halo-4-phenoxychinolinen
KR910002745A (ko) 드로프로피진의 광학적 분할방법
JP2007510630A5 (de)
DE59500893D1 (de) Verbessertes Verfahren zur Herstellung von Polyencarbonylverbindungen mit einem hohen Gehalt an dem all-E-Isomeren, sowie von deren Acetalen oder Ketalen
RU2006118316A (ru) Новый способ получения оптически чистого производного 2-морфинола

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1073618

Country of ref document: EP

REN Ceased due to non-payment of the annual fee